Recombinant Bovine Regulator of microtubule dynamics protein 3 (FAM82A2)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Bovine Regulator of Microtubule Dynamics Protein 3 (FAM82A2)

The Recombinant Bovine Regulator of Microtubule Dynamics Protein 3 (FAM82A2), also known as RMDN3 or PTPIP51, is a protein involved in various cellular processes, including microtubule dynamics, cellular differentiation, proliferation, motility, cytoskeleton formation, and apoptosis. While specific information on the recombinant bovine version is limited, the protein's functions and characteristics can be inferred from studies on its human and murine counterparts.

Biological Functions

  • Microtubule Dynamics: RMDN3 plays a crucial role in regulating microtubule dynamics, which is essential for cell division, movement, and intracellular transport .

  • Cellular Processes: It is involved in cellular differentiation, proliferation, and apoptosis, contributing to tissue development and homeostasis .

  • Cancer Association: RMDN3 has been implicated in various cancers, including prostate carcinoma and squamous cell carcinomas, suggesting its potential role in oncogenesis .

Protein Structure and Domains

  • Conserved Domains: The protein contains conserved regions (CR1 and CR2) that serve as binding sites for 14-3-3 proteins. It also features tyrosine residues that are phosphorylation sites for kinases .

  • Mitochondrial Targeting Sequence: A sequence at the N-terminal directs the protein to the mitochondria, where it can induce apoptosis .

Research Findings

While specific studies on recombinant bovine RMDN3 are not available, research on its human counterpart provides valuable insights:

Biological ProcessRole of RMDN3Implications
Cellular DifferentiationFacilitates differentiation in various tissuesEssential for development and tissue homeostasis
ProliferationInvolved in cell growth and divisionLinked to cancer progression
ApoptosisInduces apoptosis by disrupting mitochondrial membrane potentialImportant in programmed cell death and cancer

Clinical Significance

  • Cancer: Overexpression of RMDN3 has been observed in several cancers, suggesting its potential as a therapeutic target .

  • Apoptosis: Its role in apoptosis is crucial for eliminating damaged cells, which can prevent inflammation and promote tissue health .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
RMDN3; FAM82A2; FAM82C; Regulator of microtubule dynamics protein 3; RMD-3; Protein FAM82A2; Protein FAM82C
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-471
Protein Length
full length protein
Species
Bos taurus (Bovine)
Target Names
RMDN3
Target Protein Sequence
MSSLGTLGGARAGLGLLLGTAAGLGFLCALYSQRWKRTQRRGQSQSQSNSLDYTQTSEPG RQVRPLRAAPGEAGDAAVLSSLPRGQEVVLDRLEFVLTSLVALRREVEELRSSLQGLAGQ IVGEVRSHMEENQKVARRRRFPFARERSDSTGSSSVYFTAASGATFTDAESEGGYTTANA ESDYERDSERESDGDGEDEVSCETVKMGRKDSLDLEVEVALGLEPEAPEAGGSPGQEDVM PLLQQADELHQGSEQGKREGFQLLLNNKLVHGSRQDFLWRLARAYSDMCELTEEASEKRS YALSGKEEAEVALEKGNENAECHQWYAVLCGQLAEHEGIQRRIQSGFSFKEHVDKAIALK PENPMAHFLLGRWCYQVSHLSWLEKKTATALSESPLGATVQDALSSFLKAEELQPGFSKA GRIYICKCYKELGKNPEAKEWMKLALELPNVTKEDSAFQKDLEELEVILGE
Uniprot No.

Target Background

Function

Recombinant Bovine Regulator of Microtubule Dynamics Protein 3 (FAM82A2) is involved in regulating cellular calcium homeostasis. It may also participate in keratinocyte differentiation and apoptosis. Overexpression of FAM82A2 has been shown to induce apoptosis.

Database Links
Protein Families
RMDN family
Subcellular Location
Mitochondrion outer membrane; Single-pass membrane protein. Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole.

Q&A

What is FAM82A2 and what are its alternative names?

FAM82A2, officially known as Regulator of microtubule dynamics protein 3 (RMD-3), is a protein found in bovine species that plays a crucial role in microtubule dynamics regulation. The protein is also known by the name Protein FAM82C in some literature. The complete amino acid sequence consists of 471 amino acids with specific structural domains that contribute to its function in regulating microtubule behavior .

How does FAM82A2 function in microtubule dynamics regulation?

FAM82A2 functions within the complex biochemical and mechanical interplay of microtubule dynamics. Microtubules are dynamic polymers composed of αβ-tubulin subunits whose assembly and disassembly are tightly regulated processes essential for intracellular organization and chromosome segregation.

As a regulator of microtubule dynamics, FAM82A2 likely influences the conformational states of tubulin dimers. Research on microtubule-associated proteins (MAPs) has revealed that the conformational cycle of tubulin establishes the size and composition of the microtubule's stabilizing cap, and MAPs like FAM82A2 take advantage of this cycle to regulate dynamic instability .

The protein may function by:

  • Selectively targeting specific tubulin conformations

  • Influencing the balance between growth and shrinkage phases

  • Potentially mediating the coupling of conformational states throughout the microtubule lattice

  • Contributing to the mechanical forces exerted by dynamic microtubules

These functions are critical for maintaining proper cellular organization and division processes .

What are the key considerations for designing experiments with FAM82A2?

When designing experiments involving FAM82A2, researchers should follow these essential experimental design principles:

  • Clear Research Question Formulation: Begin with a well-defined research question about FAM82A2's specific role in microtubule dynamics or related cellular processes.

  • Variable Identification:

    • Independent variables: FAM82A2 concentration, presence of mutations, interaction with other proteins

    • Dependent variables: Microtubule growth rate, stability, cellular localization patterns

    • Control variables: Temperature, pH, buffer composition, cell types

  • Hypothesis Development: Formulate a testable hypothesis about how manipulating FAM82A2 will affect microtubule behavior.

  • Treatment Design: Consider treatments such as:

    • Wild-type vs. mutant FAM82A2

    • Varying concentrations of the protein

    • Presence/absence of other microtubule-associated proteins

  • Randomization and Controls: Include proper controls and random assignment to minimize bias in your experimental design.

  • Analysis Planning: Develop clear plans for statistical analysis and results reporting before conducting experiments .

How should I design a study to investigate FAM82A2 interactions with other microtubule-associated proteins?

To investigate FAM82A2 interactions with other microtubule-associated proteins (MAPs), implement a multi-phase experimental design:

Phase 1: In Vitro Binding Assays

  • Co-immunoprecipitation (Co-IP):

    • Immobilize purified FAM82A2 using antibodies

    • Incubate with cellular lysates or purified MAPs

    • Analyze bound proteins via mass spectrometry

    • Include negative controls with non-specific antibodies

  • Pull-down Assays:

    • Use tagged recombinant FAM82A2 as bait

    • Incubate with potential binding partners

    • Perform stringent washing steps

    • Analyze via Western blotting or mass spectrometry

Phase 2: Functional Interaction Studies

  • Microtubule Dynamics Assays:

    • Set up in vitro microtubule polymerization assays with:

      • FAM82A2 alone

      • Candidate MAP alone

      • FAM82A2 + candidate MAP

    • Measure parameters like growth rate, catastrophe frequency, and rescue frequency

  • Structural Analysis:

    • Employ cryo-electron microscopy to visualize FAM82A2-MAP complexes on microtubules

    • Analyze conformational changes induced by interactions

Phase 3: Cellular Validation

  • Fluorescence Microscopy:

    • Use fluorescently tagged FAM82A2 and candidate MAPs

    • Analyze co-localization in various cellular contexts

    • Implement FRET analysis to confirm direct interactions

  • Functional Perturbation:

    • Employ siRNA knockdown of FAM82A2 or candidate MAPs

    • Assess effects on microtubule organization and dynamics

    • Perform rescue experiments with wild-type or mutant proteins

This methodical approach follows established experimental design principles while incorporating the specific biochemical and mechanical considerations relevant to microtubule-associated protein research .

What controls are essential for FAM82A2 functional studies?

When conducting functional studies with FAM82A2, implement the following essential controls to ensure reliable and interpretable results:

Biochemical Assay Controls:

  • Negative Controls:

    • Buffer-only conditions (no FAM82A2)

    • Heat-inactivated FAM82A2 (denatured protein)

    • Non-relevant protein of similar size/structure

    • Vehicle controls for any solvents used

  • Positive Controls:

    • Well-characterized microtubule regulatory proteins (e.g., EB proteins)

    • Known modulators of microtubule dynamics with established effects

  • Dose-Response Controls:

    • Multiple concentrations of FAM82A2 to establish dose-dependent effects

    • Titration experiments to determine EC50/IC50 values

Cellular Assay Controls:

  • Expression Controls:

    • Empty vector transfection

    • GFP-only expression (for GFP-tagged constructs)

    • Wild-type FAM82A2 expression (when testing mutants)

  • Knockdown/Knockout Controls:

    • Non-targeting siRNA/shRNA

    • Scrambled CRISPR guide RNAs

    • Rescue experiments with RNAi-resistant constructs

  • Localization Controls:

    • Co-staining with established microtubule markers

    • Cytosolic protein markers for fractionation studies

    • Mitochondrial markers (to rule out non-specific localization)

Experimental Design Controls:

  • Technical Replicates:

    • Multiple measurements within the same experimental setup

  • Biological Replicates:

    • Repeated experiments using different protein preparations

    • Multiple cell passages or different donor sources

  • Blinding Procedures:

    • Coded samples for analysis to prevent observer bias

    • Random assignment of treatment conditions

These controls address the specific challenges in studying microtubule-associated proteins while adhering to rigorous experimental design principles. Their implementation ensures that observed effects can be confidently attributed to FAM82A2's functional properties .

How does the conformational state of FAM82A2 influence its microtubule regulatory function?

The conformational state of FAM82A2 likely plays a critical role in its microtubule regulatory function, similar to other microtubule-associated proteins (MAPs). Based on research on microtubule dynamics, we can propose that:

FAM82A2 may exist in multiple conformational states that selectively recognize different tubulin conformations within the microtubule lattice. This conformational recognition is fundamental to how MAPs regulate microtubule dynamics and stability.

Proposed Conformational Model for FAM82A2 Function:

  • Recognition of Tubulin States: FAM82A2 may preferentially bind to specific conformational states of tubulin dimers (curved, straight, or intermediate) within the microtubule lattice.

  • Allosteric Modulation: Upon binding, FAM82A2 could induce conformational changes in nearby tubulin dimers, creating a propagating effect that influences microtubule stability.

  • Nucleotide-Dependent Regulation: The protein's affinity for microtubules might be modulated by the nucleotide state of tubulin (GTP vs. GDP), allowing it to distinguish between growing and shrinking microtubule ends.

These mechanisms align with research showing that MAPs interact with the mechanical cycle of tubulin, and that biochemical regulation of microtubule dynamics through MAPs is strongly tied to the conformational changes of tubulin dimers .

To investigate this aspect experimentally, researchers should consider:

  • Cryo-electron microscopy studies to visualize FAM82A2-bound microtubules

  • FRET-based conformational sensors to detect FAM82A2 structural changes

  • Mutagenesis of potential conformation-sensing domains in FAM82A2

  • In vitro reconstitution assays with tubulin mutants locked in specific conformations

Understanding these conformational dynamics would significantly advance our knowledge of how FAM82A2 contributes to microtubule regulation in bovine cellular systems .

What methodologies are most effective for studying FAM82A2 function in various cellular contexts?

To comprehensively investigate FAM82A2 function across cellular contexts, researchers should employ a multi-methodological approach that addresses both biochemical and mechanical aspects of microtubule regulation:

Table 1: Recommended Methodologies for Studying FAM82A2 Function

MethodologyApplicationAdvantagesConsiderations
TIRF MicroscopyDynamic microtubule assaysDirect visualization of single microtubule dynamics; real-time kinetic dataRequires specialized equipment; limited to in vitro systems
Cryo-Electron MicroscopyStructural analysisHigh-resolution visualization of FAM82A2-microtubule interactions; conformational detailsSample preparation challenges; computational analysis complexity
Live-Cell ImagingCellular microtubule dynamicsPhysiological context; dynamic behavior in vivoLower resolution; potential fluorescent tag artifacts
CRISPR-Cas9 Genome EditingLoss-of-function studiesPrecise genetic manipulation; complete protein eliminationOff-target effects; compensation by related proteins
Optogenetic ControlAcute manipulation of FAM82A2Temporal precision; spatially restricted activationRequires protein engineering; potential light toxicity
Biomechanical Force MeasurementsForce generation/responseQuantification of mechanical propertiesTechnical complexity; specialized equipment needs
Proximity Labeling (BioID/APEX)Interaction network mappingIdentifies transient and stable interactions; works in native cellular environmentNon-specific labeling; requires optimization

Implementation Strategy:

  • Combined Approaches: For most robust results, integrate multiple methodologies. For example, validate in vitro TIRF microscopy findings with corresponding live-cell imaging.

  • Context-Specific Adaptations: Modify protocols based on cell type and physiological state:

    • Dividing cells: Focus on mitotic spindle functions

    • Neurons: Examine axonal transport and growth cone dynamics

    • Epithelial cells: Investigate apicobasal microtubule organization

  • Quantitative Analysis Pipeline: Develop standardized analysis workflows for:

    • Microtubule growth/shortening rates

    • Catastrophe and rescue frequencies

    • Spatial distribution patterns

    • Force generation measurements

  • Control Experiments: Include parallel studies of known microtubule regulators (EB1, XMAP215) for comparative analysis

This comprehensive methodological approach accounts for the complex interplay between biochemical and mechanical aspects of microtubule regulation, enabling researchers to elucidate FAM82A2's specific contributions across diverse cellular contexts .

What is the relationship between FAM82A2 and other regulators in the microtubule dynamics pathway?

The relationship between FAM82A2 and other regulators in the microtubule dynamics pathway likely involves complex interaction networks and functional cooperativity. While specific data on FAM82A2 interactions is limited in the provided search results, we can propose a model based on known principles of microtubule regulation:

Hierarchical Regulatory Framework:

FAM82A2 likely functions within a hierarchical network of microtubule-associated proteins (MAPs) that collectively fine-tune microtubule dynamics. This network would include:

  • Nucleation Regulators: Proteins that initiate microtubule formation (γ-tubulin, augmin complex)

  • Plus-End Tracking Proteins (+TIPs): Proteins like EB1/EB3 that recognize growing microtubule ends

  • Lattice-Binding MAPs: Stabilizers like MAP2 and tau that bind along the microtubule length

  • Microtubule-Severing Enzymes: Proteins like katanin and spastin that cut microtubules

  • Motor Proteins: Kinesins and dyneins that transport cargo and influence dynamics

FAM82A2, as a regulator of microtubule dynamics, may interact with multiple components of this network, particularly through conformational coupling mechanisms similar to those described for EB proteins .

Proposed Interaction Model:

  • Cooperative Binding: FAM82A2 may cooperate with EB proteins to recognize specific tubulin conformations at growing microtubule ends.

  • Competitive Interactions: It might compete with other MAPs for binding sites on the microtubule lattice, creating a balance of stabilizing and destabilizing influences.

  • Sequential Action: FAM82A2 could function in a sequential manner with other regulators, with its binding creating or masking binding sites for subsequent factors.

  • Signaling Integration: It may serve as an integration point for cellular signaling pathways that regulate microtubule dynamics in response to environmental cues.

To investigate these relationships, researchers should consider:

  • Reconstitution experiments with defined combinations of MAPs

  • Competition binding assays

  • Sequential addition experiments

  • Proteomics approaches to map the complete interaction network

Understanding these relationships will provide insight into how FAM82A2 contributes to the precise spatiotemporal control of microtubule dynamics required for normal cellular function .

What purification methods are most effective for obtaining functional recombinant FAM82A2?

Obtaining high-purity, functional recombinant FAM82A2 requires a carefully optimized purification strategy. Based on common approaches for microtubule-associated proteins, the following protocol is recommended:

Expression System Selection:

  • Bacterial Expression (E. coli):

    • Advantages: High yield, cost-effective, rapid production

    • Recommended strains: BL21(DE3), Rosetta 2(DE3) for rare codon optimization

    • Considerations: May lack post-translational modifications; potential folding issues

  • Insect Cell Expression (Baculovirus):

    • Advantages: Better folding, some post-translational modifications

    • Recommended cells: Sf9 or High Five™ cells

    • Considerations: Higher cost, longer production time, better for complex proteins

  • Mammalian Expression:

    • Advantages: Native-like modifications, optimal folding

    • Recommended cells: HEK293F, CHO cells

    • Considerations: Highest cost, lowest yield, necessary for fully functional studies

Optimized Purification Protocol:

  • Initial Lysis:

    • Buffer composition: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 10% glycerol

    • Protease inhibitors: PMSF (1 mM), leupeptin (1 μg/ml), pepstatin (1 μg/ml)

    • Lysis method: Sonication (bacteria) or gentle detergent treatment (insect/mammalian)

  • Affinity Chromatography:

    • Primary tag: His6 or GST tag

    • Column: Ni-NTA or Glutathione Sepharose

    • Elution: Imidazole gradient (20-250 mM) or reduced glutathione (10 mM)

    • Cleavage: TEV or PreScission protease for tag removal

  • Ion Exchange Chromatography:

    • Column: Q Sepharose (anion exchange) based on FAM82A2's theoretical pI

    • Gradient: 50-500 mM NaCl in 20 mM Tris-HCl pH 7.5, 1 mM DTT

  • Size Exclusion Chromatography:

    • Column: Superdex 200

    • Buffer: 20 mM HEPES pH 7.2, 150 mM KCl, 1 mM MgCl2, 1 mM DTT

    • Flow rate: 0.5 ml/min to maximize resolution

  • Quality Control:

    • Purity assessment: SDS-PAGE (>95% purity)

    • Identity confirmation: Western blot and mass spectrometry

    • Functional validation: Microtubule co-sedimentation assay

Storage Conditions:

  • Short-term (1-2 weeks): 4°C in 50% glycerol

  • Long-term: Aliquot and flash-freeze in liquid nitrogen, store at -80°C

  • Avoid repeated freeze-thaw cycles

This purification approach has been optimized based on general principles for obtaining functional microtubule-associated proteins and would need to be specifically adapted for FAM82A2 based on its unique properties .

How can I establish reliable in vitro assays to measure FAM82A2's effect on microtubule dynamics?

To establish reliable in vitro assays for measuring FAM82A2's effects on microtubule dynamics, implement the following protocol:

Total Internal Reflection Fluorescence (TIRF) Microscopy Assay

This gold-standard approach allows direct visualization of individual microtubules and precise quantification of dynamic parameters.

Materials:

  • Purified bovine brain tubulin (unlabeled)

  • Fluorescently labeled tubulin (5-10% of total)

  • Purified recombinant FAM82A2

  • Flow chambers with functionalized coverslips

  • GTP and ATP

  • Oxygen scavenging system

Protocol:

  • Chamber Preparation:

    • Coat glass coverslips with biotin-PEG

    • Incubate with neutravidin

    • Attach biotinylated microtubule seeds (GMPCPP-stabilized)

  • Reaction Mixture:

    • Tubulin (10-15 μM final concentration)

    • FAM82A2 (variable concentrations, 0-1 μM)

    • GTP (1 mM)

    • Oxygen scavenging system to prevent photobleaching

  • Image Acquisition:

    • Capture time-lapse images at 1-2 second intervals

    • Monitor at controlled temperature (30-37°C)

    • Include multiple fields of view per condition

  • Quantitative Analysis:

    • Measure:

      • Growth rate (nm/sec)

      • Shrinkage rate (nm/sec)

      • Catastrophe frequency (events/min)

      • Rescue frequency (events/min)

      • Pause duration (sec)

Microtubule Pelleting Assay

Protocol:

  • Microtubule Polymerization:

    • Mix tubulin (5-20 μM) with GTP in assembly buffer

    • Incubate at 37°C for 30 minutes

    • Stabilize with taxol (10 μM)

  • Binding Reaction:

    • Incubate polymerized microtubules with varying FAM82A2 concentrations

    • Include controls: buffer-only, BSA, known MAP

  • Ultracentrifugation:

    • Spin at 100,000 × g for 30 minutes at 25°C

    • Separate pellet (microtubule-bound) from supernatant (unbound)

  • Analysis:

    • SDS-PAGE analysis of pellet and supernatant fractions

    • Quantify protein amounts by densitometry

    • Calculate bound vs. free protein ratio

    • Determine dissociation constant (Kd)

Data Interpretation:

Construct comprehensive data tables showing:

  • Dynamic parameters at different FAM82A2 concentrations

  • Comparison with control conditions

  • Dose-response relationships

  • Statistical significance of observed effects

Table 2: Example Data Format for FAM82A2 Effects on Microtubule Dynamics

FAM82A2 Conc. (nM)Growth Rate (nm/sec)Catastrophe Freq. (events/min)Rescue Freq. (events/min)Binding Affinity (μM)
0 (Control)3.5 ± 0.40.2 ± 0.050.1 ± 0.03N/A
103.8 ± 0.30.18 ± 0.040.12 ± 0.030.8 ± 0.2
504.2 ± 0.30.15 ± 0.030.14 ± 0.020.7 ± 0.1
1004.5 ± 0.50.12 ± 0.040.18 ± 0.040.65 ± 0.15
5004.8 ± 0.40.10 ± 0.030.20 ± 0.050.6 ± 0.1

These assays provide complementary data on both the kinetic and equilibrium aspects of FAM82A2's interaction with microtubules, enabling a comprehensive understanding of its regulatory mechanisms .

What imaging techniques are most suitable for visualizing FAM82A2-microtubule interactions in cellular contexts?

To effectively visualize FAM82A2-microtubule interactions in cellular contexts, researchers should employ a multi-modal imaging approach that captures both spatial and temporal dimensions of these dynamics. The following techniques are particularly well-suited for this purpose:

Super-Resolution Microscopy Techniques

Structured Illumination Microscopy (SIM):

  • Resolution: ~100 nm (2× better than confocal)

  • Applications: Visualizing FAM82A2 distribution along microtubule networks

  • Advantages: Compatible with live-cell imaging; relatively fast acquisition

  • Sample preparation: Standard immunofluorescence or fluorescent protein tagging

Stochastic Optical Reconstruction Microscopy (STORM)/Photo-Activated Localization Microscopy (PALM):

  • Resolution: ~20-30 nm

  • Applications: Precise localization of FAM82A2 relative to microtubule lattice

  • Advantages: Exceptional resolution; compatible with multi-color imaging

  • Sample preparation: Requires photo-switchable fluorophores; typically fixed samples

Stimulated Emission Depletion (STED) Microscopy:

  • Resolution: ~30-80 nm

  • Applications: Studying FAM82A2 dynamics at microtubule plus-ends

  • Advantages: Compatible with live imaging; direct visualization without reconstruction

  • Sample preparation: Requires specific fluorophores; higher illumination intensity

Advanced Live-Cell Imaging Approaches

Spinning Disk Confocal Microscopy:

  • Resolution: ~200 nm

  • Applications: Long-term visualization of FAM82A2 dynamics

  • Advantages: Reduced phototoxicity; high temporal resolution; ideal for 3D time-lapse

  • Sample preparation: Fluorescent protein tagging of FAM82A2 and microtubule markers

Total Internal Reflection Fluorescence (TIRF) Microscopy:

  • Resolution: Standard lateral (~200 nm) but excellent axial (~100 nm)

  • Applications: Visualizing FAM82A2 at microtubules near the cell cortex

  • Advantages: Exceptional signal-to-noise ratio; reduced background; ideal for single-molecule tracking

  • Sample preparation: Limited to structures within ~100-200 nm of the coverslip

Molecular Interaction Imaging Techniques

Förster Resonance Energy Transfer (FRET):

  • Resolution: Below optical limit for detecting interactions (1-10 nm)

  • Applications: Direct visualization of FAM82A2-tubulin binding dynamics

  • Advantages: Reports on molecular proximity in living cells

  • Sample preparation: Requires fluorescent protein pair tagging

Fluorescence Lifetime Imaging Microscopy (FLIM):

  • Resolution: Standard optical (~200 nm) but can detect molecular interactions

  • Applications: Quantifying FAM82A2-microtubule binding states

  • Advantages: Less sensitive to concentration variations than intensity-based FRET

  • Sample preparation: Requires specific fluorophores with appropriate lifetime properties

Implementation Strategy

Correlative Approach:

Labeling Strategy for Optimal Results:

  • FAM82A2: C-terminal tag minimizes functional interference (based on structural predictions)

  • Microtubules: SiR-tubulin for live imaging or anti-α-tubulin antibodies for fixed cells

  • Consider dual-color single-molecule techniques to track individual FAM82A2 molecules along microtubules

Controls and Validation:

  • Perform functionality assays to ensure tagged FAM82A2 retains native activity

  • Include colocalization with established microtubule +TIP proteins (EB1, CLIP-170)

  • Correlate fluorescence data with electron microscopy for structural validation

This comprehensive imaging approach enables researchers to characterize FAM82A2-microtubule interactions across multiple spatial and temporal scales, from single-molecule dynamics to network-level organization .

How should I address inconsistent results in FAM82A2 functional assays?

When confronted with inconsistent results in FAM82A2 functional assays, implement a systematic troubleshooting approach that addresses both technical and biological sources of variability:

Systematic Troubleshooting Protocol:

  • Protein Quality Assessment

    First, evaluate if your recombinant FAM82A2 preparation is consistent:

    • Stability Testing:

      • Run time-course experiments storing protein at 4°C, measuring activity daily

      • Analyze samples by SDS-PAGE to detect degradation products

      • Consider size-exclusion chromatography to detect aggregation

    • Batch Comparison:

      • Run side-by-side assays with different protein preparations

      • Document production conditions for each batch (expression time, purification steps)

      • Normalize activity to protein concentration and purity percentage

  • Assay Parameter Optimization

    Systematically test and optimize critical parameters:

    • Buffer Composition Matrix:

    Buffer ComponentTest RangeOptimal Value
    pH6.5 - 8.0 (0.5 increments)Determine experimentally
    Salt (NaCl/KCl)50 - 200 mM (50 mM increments)Determine experimentally
    Mg2+0.5 - 5 mM (1 mM increments)Determine experimentally
    Reducing agent0 - 5 mM DTT or β-MEDetermine experimentally
    Glycerol0 - 10%Determine experimentally
    • Temperature Sensitivity:

      • Test activity at 25°C, 30°C, and 37°C

      • Monitor protein stability at each temperature

    • Time-Dependent Effects:

      • Establish appropriate time windows for measurements

      • Document time points precisely in protocols

  • Technical Variability Control

    Implement rigorous controls to minimize technical variability:

    • Standardized Protocols:

      • Create detailed step-by-step protocols with precise timing

      • Document all deviations for correlation with results

    • Equipment Calibration:

      • Verify pipette calibration monthly

      • Check microscope alignment and light source intensity regularly

      • Validate temperature control systems

    • Reagent Standardization:

      • Use single batches of critical reagents (especially tubulin)

      • Aliquot reagents to minimize freeze-thaw cycles

      • Include internal standards in each experiment

  • Biological Variability Assessment

    Consider inherent biological variables that may affect results:

    • Post-Translational Modifications:

      • Test for phosphorylation state using Phos-tag gels

      • Consider mass spectrometry to identify modifications

    • Binding Partners:

      • Check for co-purifying proteins via silver staining

      • Consider the presence/absence of tubulin isotypes

    • Conformational States:

      • Test activity with pre-incubation at different temperatures

      • Consider adding stabilizing agents if the protein shows conformational instability

  • Statistical Approach for Data Reconciliation

    Implement robust statistical methods to address remaining variability:

    • Increase replicate numbers (minimum n=5 for each condition)

    • Apply appropriate statistical tests (ANOVA with post-hoc analysis)

    • Consider hierarchical statistical models that account for batch effects

    • Report variability transparently, with clear error bars and p-values

By systematically addressing these potential sources of variability, researchers can establish more consistent and reliable FAM82A2 functional assays, leading to more reproducible and trustworthy research findings .

What are the common pitfalls in interpreting FAM82A2's effects on microtubule dynamics?

Conceptual and Methodological Pitfalls:

  • Confusing Direct vs. Indirect Effects

    Pitfall: Attributing observed changes in microtubule dynamics directly to FAM82A2 when they may result from interactions with other MAPs or signaling pathways.

    Solution:

    • Perform in vitro reconstitution experiments with purified components

    • Systematically test FAM82A2 in the presence/absence of other MAPs

    • Use proximity labeling approaches to identify direct interaction partners

    • Compare cellular vs. in vitro effects to identify context-dependent behaviors

  • Overlooking Concentration-Dependent Effects

    Pitfall: Testing at a single concentration and missing potential biphasic effects where FAM82A2 may promote polymerization at low concentrations but inhibit it at high concentrations.

    Solution:

    • Perform careful dose-response experiments

    • Estimate physiological concentration ranges for FAM82A2

    • Create concentration-effect curves for multiple parameters (growth rate, catastrophe frequency, etc.)

  • Neglecting Spatial and Temporal Resolution

    Pitfall: Using imaging approaches with insufficient resolution to capture the true dynamics of FAM82A2-microtubule interactions.

    Solution:

    • Match temporal sampling to the speed of the process (consider higher frame rates)

    • Ensure spatial resolution is appropriate for distinguishing localization patterns

    • Use complementary techniques (bulk biochemistry and single-molecule approaches)

  • Misinterpreting Static vs. Dynamic Properties

    Pitfall: Confusing FAM82A2's effects on static binding (affinity for microtubules) with its effects on dynamic behavior (influence on growth/shrinkage rates).

    Solution:

    • Clearly separate binding measurements from dynamic parameter measurements

    • Use experimental designs that can distinguish between:

      • Nucleation effects

      • Elongation rate effects

      • Catastrophe/rescue modulation

      • Pause induction

Data Analysis and Interpretation Pitfalls:

Interpretive Framework:

To avoid these pitfalls, develop a comprehensive analytical framework that:

  • Distinguishes between direct binding effects and modulatory influence

  • Separates effects on different phases of microtubule dynamic instability

  • Considers concentration-dependent responses

  • Accounts for potential cooperative or competitive interactions with other factors

  • Integrates findings across multiple experimental approaches

This systematic approach will lead to more accurate interpretations of FAM82A2's true functional role in regulating microtubule dynamics .

How can I integrate data from different experimental approaches to build a comprehensive model of FAM82A2 function?

Integrating diverse experimental data to build a comprehensive model of FAM82A2 function requires a systematic approach that bridges multiple scales of analysis, from molecular interactions to cellular phenotypes. The following framework provides a structured methodology for this integration:

Multi-Scale Data Integration Framework

  • Establish a Core Data Repository

    Create a centralized database that organizes all experimental data related to FAM82A2 with standardized formats and metadata:

    • Data Categories:

      • Structural data (protein domains, conformational states)

      • Biochemical data (binding affinities, enzymatic activities)

      • Cellular data (localization patterns, phenotypic effects)

      • Systems data (interaction networks, pathway analysis)

    • Standardized Annotation:

      • Experimental conditions (pH, salt, temperature)

      • Cell types or reconstitution systems

      • Statistical significance measures

      • Raw data availability

  • Develop Multi-Parameter Activity Profiles

    Rather than analyzing individual parameters in isolation, create comprehensive activity profiles that capture FAM82A2's effects across multiple dimensions:

    Table 3: Multi-Parameter Activity Profile Template

    Parameter CategorySpecific MeasurementsIn Vitro DataCellular DataCorrelation Strength
    Binding PropertiesMT affinity (Kd)X μMN/AN/A
    Binding stoichiometryX molecules/μmX molecules/μmHigh
    Lattice vs. tip preferenceRatio X:YRatio X:YMedium
    Dynamic EffectsGrowth rate modulationX% changeX% changeHigh
    Catastrophe frequencyX% changeX% changeMedium
    Rescue frequencyX% changeX% changeLow
    Mechanical EffectsForce generationX pNN/AN/A
    Mechanical stabilityX% changeN/AN/A
    Biochemical ActivitiesGTPase modulationX% changeN/AN/A
    Nucleotide exchangeX% changeN/AN/A
  • Implement Cross-Validation Approaches

    Systematically compare results across different experimental platforms to identify robust findings and technique-specific artifacts:

    • Orthogonal Technique Comparison:

      • Verify binding observations using both biochemical (pelleting) and imaging (TIRF) approaches

      • Confirm localization patterns with both antibody staining and fluorescent protein tagging

    • Scale Bridging:

      • Test whether in vitro observations predict cellular phenotypes

      • Determine if computational models based on biochemical data can predict cellular outcomes

  • Develop Integrative Computational Models

    Create mathematical models that can synthesize diverse data types into a coherent functional framework:

    • Model Types:

      • Kinetic models of microtubule dynamics incorporating FAM82A2 parameters

      • Structural models of FAM82A2-tubulin interactions

      • Network models of FAM82A2's position in the cellular interactome

    • Model Validation:

      • Test model predictions with targeted experiments

      • Refine models iteratively based on new data

      • Quantify model uncertainty and sensitivity to parameter variation

  • Contextual Analysis

    Examine how FAM82A2's function varies across different cellular and physiological contexts:

    • Comparative Analysis:

      • Cell-type specific effects

      • Developmental stage variations

      • Species-specific differences

    • Perturbation Response:

      • FAM82A2 function under stress conditions

      • Response to drug treatments

      • Genetic background effects

Implementation Strategy:

  • Begin with Core Mechanism Identification:

    • Establish FAM82A2's fundamental biochemical activities

    • Determine direct vs. indirect effects on microtubules

    • Identify critical domains for various functions

  • Expand to Regulatory Networks:

    • Map FAM82A2's interactions with other microtubule regulators

    • Identify upstream regulators and downstream effectors

    • Determine pathway integration points

  • Extend to Cellular Functions:

    • Connect molecular activities to cellular phenotypes

    • Establish causal relationships through perturbation experiments

    • Develop cell-type specific functional models

By systematically integrating data across these levels, researchers can develop a comprehensive model of FAM82A2 function that captures both its core mechanistic activities and its context-dependent roles in cellular processes .

What are the key unresolved questions about FAM82A2 function?

Despite advances in understanding microtubule dynamics regulation, several critical questions about FAM82A2 remain unresolved. These knowledge gaps represent important opportunities for future research:

  • Structural Mechanism of Action

    The precise structural basis for how FAM82A2 interacts with microtubules remains unclear. Key questions include:

    • Which domains directly contact tubulin?

    • Does FAM82A2 recognize specific tubulin conformations?

    • How does binding induce conformational changes in the microtubule lattice?

    Resolution will require high-resolution structural studies of FAM82A2-tubulin complexes.

  • Regulation of FAM82A2 Activity

    The mechanisms controlling FAM82A2's activity in cells are poorly understood:

    • What post-translational modifications regulate its function?

    • Which signaling pathways modulate its activity?

    • How is its expression controlled in different cell types?

    Systematic proteomic and genetic studies are needed to elucidate these regulatory mechanisms.

  • Functional Redundancy and Specialization

    The relationship between FAM82A2 and related proteins requires clarification:

    • What functional overlap exists with other microtubule regulators?

    • Does FAM82A2 have unique functions not shared by related proteins?

    • How do cells compensate for loss of FAM82A2?

    Comparative studies with related proteins and analysis of combinatorial knockdowns would address these questions.

  • Tissue-Specific Functions

    The role of FAM82A2 in different tissues and developmental contexts remains largely unexplored:

    • Does FAM82A2 function differently in specialized cell types?

    • What is its role during development and differentiation?

    • Are there tissue-specific interaction partners?

    Tissue-specific knockout models and developmental studies would provide valuable insights.

  • Disease Relevance

    The potential contribution of FAM82A2 dysfunction to pathological conditions is an important open question:

    • Is FAM82A2 dysregulation associated with specific diseases?

    • Could it be a therapeutic target for conditions involving microtubule dysfunction?

    • Are there natural variants with altered function?

    Clinical correlation studies and disease model systems could address these questions.

Addressing these unresolved questions will require interdisciplinary approaches combining structural biology, biochemistry, cell biology, genetics, and systems biology. The answers will significantly advance our understanding of microtubule regulation and potentially reveal new therapeutic opportunities .

What future directions should FAM82A2 research take to advance our understanding of microtubule dynamics?

To advance our understanding of microtubule dynamics through FAM82A2 research, future investigations should pursue several strategic directions that leverage emerging technologies and interdisciplinary approaches:

Structural and Conformational Dynamics

Future research should employ advanced structural biology techniques to elucidate FAM82A2's molecular mechanism:

  • Cryo-electron microscopy of FAM82A2-decorated microtubules at near-atomic resolution

  • Time-resolved structural studies to capture conformational changes during binding

  • Nuclear magnetic resonance (NMR) studies of dynamic regions

  • Hydrogen-deuterium exchange mass spectrometry to map conformational changes

  • Molecular dynamics simulations to predict conformational coupling mechanisms

These approaches would reveal how FAM82A2 recognizes specific tubulin conformations and influences the mechanical properties of the microtubule lattice.

Systems-Level Integration

Research should position FAM82A2 within the broader context of microtubule regulation:

  • Comprehensive interactome mapping using proximity labeling techniques

  • Network analysis to identify functional modules and pathway connections

  • Synthetic biology approaches to create minimal microtubule regulatory systems

  • Mathematical modeling of how multiple regulators function together

  • Evolutionary analysis to understand conservation and specialization

This systems perspective would reveal how FAM82A2 cooperates with other factors to achieve precise control of microtubule dynamics.

Spatiotemporal Regulation

Future studies should investigate how FAM82A2 activity is regulated in space and time:

  • Development of biosensors to monitor FAM82A2 activation state in living cells

  • Optogenetic tools to precisely control FAM82A2 activity

  • Super-resolution imaging of FAM82A2 dynamics during cellular processes

  • Single-molecule tracking to reveal binding kinetics and diffusion properties

  • Correlation with microtubule nucleotide state and age markers

These approaches would connect molecular mechanisms to cellular functions and reveal how FAM82A2 contributes to spatiotemporal organization.

Mechanical Force Integration

Research should explore the mechanical aspects of FAM82A2 function:

  • Optical trapping experiments to measure force generation and resistance

  • Microfluidic approaches to apply controlled forces to FAM82A2-microtubule systems

  • Traction force microscopy to correlate cellular forces with FAM82A2 activity

  • Development of tension-sensitive probes for microtubules

  • Computational modeling of mechanochemical coupling

This mechanical perspective would illuminate how FAM82A2 might participate in force generation or sensing within the cytoskeleton.

Translational Applications

Future research should explore potential therapeutic applications:

  • Screening for small molecules that modulate FAM82A2-microtubule interactions

  • Investigation of FAM82A2's role in cancer cell division and migration

  • Analysis of neurodegenerative disease models for altered FAM82A2 function

  • Development of FAM82A2-based biomarkers for microtubule dysregulation

  • Exploration of tissue-specific functions relevant to targeted therapies

These translational directions would leverage fundamental knowledge for potential clinical applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.